Renovascular hypertension update

Current Hypertension Reports

Volumn 8, Issue 6, 2006, Pages 521-527

  Textor, Stephen C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TEMPOL;

AGING; ANTIHYPERTENSIVE THERAPY; CLINICAL TRIAL; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DRUG EFFICACY; ENDOVASCULAR SURGERY; FIBROMUSCULAR DYSPLASIA; HUMAN; HYPERTENSION; KIDNEY ARTERY EMBOLISM; KIDNEY ARTERY STENOSIS; KIDNEY DYSFUNCTION; NEPHROSCLEROSIS; NON INVASIVE PROCEDURE; NONHUMAN; OUTCOMES RESEARCH; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RENAL ARTERY ANEURYSM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR DISEASE; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; REVIEW; RISK ASSESSMENT; STENT; TREATMENT FAILURE;

DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION, RENOVASCULAR; MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIALS; RENAL ARTERY OBSTRUCTION; STENTS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER;

EID: 33751568473     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-006-0032-9     Document Type: Review

References (49)

1. Murphy TP, Soares G, Kim M: Increase in utilization of percutaneous renal artery interventions by Medicare beneficiaries 1996-2000. AJR Am J Roentgenol 2004, 183:561-568.
2. Garovic V, Textor SC: Renovascular hypertension: current concepts. Semin Nephrol 2005, 25:261-271.
3. Little MA, O'Brien E, Owens P, et al.: A longitudinal study of the yield and clinical utility of a specifically designed secondary hypertension investigation protocol. Ren Fail 2003, 25:709-717.
4. Surowiec SM, Sivamurthy N, Rhodes JM, et al.: Percutaneous therapy for renal artery fibromuscular dysplasia. Ann Vasc Surg 2003, 17:650-655.
5. Alhadad A, Mattiasson I, Ivancev K, et al.: Revasularisation of renal artery stenosis caused by fibromuscular dysplasia: effects on blood pressure during 7-year follow-up are influenced by duration of hypertension and branch artery stenosis. J Hum Hypertens 2005, 19:761-767.
6. Carmo M, Bower TC, Mozes G, et al.: Surgical management of renal fibromuscular dysplasia: challenges in the endovascular era. Ann Vasc Surg 2005, 19:208-217.
7. Salifu MO, Haria DM, Badero O, et al.: Challenges in the diagnosis and management of renal artery stenosis. Curr Hypertens Rep 2005, 7:219-227.
8. Hansen KJ, Edwards MS, Craven TE, et al.: Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 2002, 36:443-451.
9. Edwards MS, Craven TE, Burke GL, et al.: Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch Intern Med 2005, 165:207-213.
10. Kalra PA, Guo H, Kausz AT, et al.: Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 2005, 68:293-301.
11. Buller CE, Nogareda JG, Ramanathan K, et al.: The profile of cardiac patients with renal artery stenosis. J Am Coll Cardiol 2004, 43:1606-1613.
12. Johansson M, Herlitz H, Jensen G, et al.: Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens 1999, 17(12 Pt 1):1743-1750.
13. Gao SA, Johansson M, Rundqvist B, et al.: Reduced spontaneous baroreceptor sensitivity in patients with renovascular hypertension. J Hypertens 2002, 20:111-116.
14. Iantorno M, Pola R, Schinzari F, et al.: Association between altered circadian blood pressure profile and cardiac end-organ damage in patients with renovascular hypertension. Cardiology 2003, 100:114-119.
15. Grisk O, Rettig R: Interactions between the sympathetic nervous system and the kidneys in arterial hypertension. Cardiovasc Res 2004, 61:238-246.
16. Cervenka L, Horacek V, Vaneckova I, et al.: Essential role of AT1A receptor in the development of 2K1C hypertension. Hypertension 2002, 40:735-741.
17. Crowley SD, Gurley SB, Oliverio MI, et al.: Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 2005, 115:1092-1099.
18. Lerman LO, Nath KA, Rodriguez-Porcel M, et al.: Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001, 37(2 Pt 2):541-546.
19. Jung O, Schreiber JG, Geiger H, et al.: gp9lphox-containing NADPH oxidase mediates endothelial dysfunction in reno-vascular hypertension. Circulation 2004, 109:1795-1801.
20. Welch WJ, Mendonca M, Aslam S, Wilcox CS: Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K,1C kidney. Hypertension 2003, 41(3 Pt 2):692-696.
21. Parildar M, Parildar Z, Oran I, et al.: Nitric oxide and oxidative stress in atherosclerotic renovascular hypertension: effect of endovascular treatment. J Vasc Interv Radiol 2003, 14:887-892.
22. Chade AR, Rodriguez-Porcel M, Grande JP, et al.: Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 2002, 106:1165-1171.
23. Chade AR, Rodriguez-Porcel M, Grande JP, et al.: Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol 2003, 23:1295-1301.
24. Nordmann AJ, Woo K, Parkes R, Logan AG: Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? a meta-analysis of randomized controlled trials. Am J Med 2003, 114:44-50.
25. Ives NJ, Wheatley K, Stowe RL, et al.: Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transplant 2003, 18:298-304.
26. van Jaarsveld BC, Krijnen P, Pieterman H, et al.: The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000, 342:1007-1014.
27. Silva JA, Chan AW, White CJ, et al.: Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation 2005, 111:328-333.
28. Vasbinder GB, Nelemans PJ, Kessels AG, et al.: Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Int Med 2001, 135:401-411.
29. Gandy SJ, Sudarshan TA, Sheppard DG, et al.: Dynamic MRI contrast enhancement of renal cortex: a functional assessment of renovascular disease in patients with renal artery stenosis. J Magn Reson Imaging 2003, 18:461-466.
30. Tan KT, van Beek EJ, Brown PW, et al.: Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol 2002, 57:617-624.
31. Vasbinder GB, Nelemans PJ, Kessels AG, et al.: Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004, 141:674-682.
32. Napoli V, Pinto S, Bargellini I, et al.: Duplex ultrasonographic study of the renal arteries before and after renal artery stenting. Eur Radiol 2002, 12:796-803.
33. Radermacher J, Haller H: The right diagnostic work-up: investigating renal and renovascular disorders. J Hypertens Suppl 2003,21:S19-S24.
34. Zeller T, Frank U, Muller C, et al.: Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation 2003, 108:2244-2249.
35. Textor SC: Pitfalls in imaging for renal artery stenosis. Ann Int Med 2004, 141:730-731.
36. Giles TD, Sander GE: Beyond the usual strategies for blood pressure reduction: therapeutic considerations and combination therapies. J Clin Hypertens (Greenwich) 2001, 3:346-353.
37. Murphy TP, Cooper CJ, Dworkin LD, et al.: The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. J Vasc Interv Radiol 2005, 16:1295-1300.
38. Losito A, Gaburri M, Errico R, et al.: Survival of patients with renovascular disease and ACE inhibition. Clin Nephrol 1999, 52:339-343.
39. Kiykim AA, Boz M, Ozer C, et al.: Two episodes of anuria and acute pulmonary edema in a losartan-treated patient with solitary kidney. Heart Vessels 2004, 19:52-54.
40. Fernando D, Garasic J: Percutaneous intervention for renovascular disease: rationale and patient selection. Curr Opin Cardiol 2004, 19:582-588.
41. Butterly DW, Schwab SJ: Renal artery stenosis: the case for conservative management. Mayo Clin Proc 2000, 75:435-436.
42. Plouin PF: Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management. Am J Kidney Dis 2003, 42:851-857.
43. Schillinger M, Minar E, Ahmadi R: Treating renal artery stenosis. A statement pro endovascular therapy. Herz 2004, 29:68-75.
44. White CJ: Catheter-based therapy for atherosclerotic renal artery stenosis. Circulation 2006, 113:1464-1473.
45. Ivanovic V, McKusick MA, Johnson CM 3rd, et al.: Renal artery stent placement: complications at a single tertiary care center. J Vasc Interv Radiol 2003, 14(2 Pt 1):217-225.
46. Isles CG, Robertson S, Hill D: Management of renovascular disease: a review of renal artery stenting in ten studies. QJM 1999, 92:159-167.
47. Topol EJ, Yadav JS: Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000, 101:570-580.
48. Garovic VD, Textor SC: Renovascular hypertension and ischemic nephropathy. Circulation 2005, 112:1362-1374.
49. Dorros G, Jaff M, Mathiak L, et al.: Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1,058 successful patients. Catheter Cardiovasc Interv 2002, 55:182-188.